Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Cell Proliferation|July 10, 2026
iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized MiceMin Zhang, Zhiqian Wang, Yanhong Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis]Yan-Rong Liu, Shan-Shan Chen, Yan Chang, et al.
Leukemia Research|December 3, 2014
Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese centerYa-Zhen Qin, Hong-Hu Zhu, Qian Jiang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 7, 2018
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving ChemotherapyYa-Zhen Qin, Ting Zhao, Hong-Hu Zhu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 28, 2006
[Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia]Ya-Zhe Wang, Yan Chang, Hong-Hu Zhu, et al.
Chinese Medical Journal|September 29, 2009
Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemiaXiao-hui Zhang, Yu Hu, Li Bao, et al.
Hematological Oncology|February 28, 2024
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysisRong Wang, Yi Zhang, Jie Chang, et al.
British Journal of Haematology|March 25, 2021
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemiaHuanping Wang, Yile Zhou, Xin Huang, et al.
Frontiers in Oncology|December 16, 2020
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic LeukemiaJianai Sun, Yinjun Lou, Jingjing Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 28, 2008
[PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease]Ya-zhen Qin, Jin-lan Li, Hong-hu Zhu, et al.
Pageof 13